Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vacuolar protein sorting-associated protein 13D (VPS13D) is a large, conserved intermembrane lipid transfer protein involved in maintaining mitochondrial and peroxisomal health by mediating lipid transport at membrane contact sites, especially between the endoplasmic reticulum, mitochondria, and peroxisomes[1][2][3]. It contains distinctive domains such as a ubiquitin-associated (UBA) domain, enabling binding to ubiquitin chains and involvement in mitophagy, the process by which damaged mitochondria are selectively cleared[4]. VPS13D is crucial for proper mitochondrial morphology, distribution, and DNA maintenance; its deficiency leads to mitochondrial dysfunction, abnormal organelle morphology, and loss of peroxisomes, typically resulting in severe, recessive neurological disorders such as spinocerebellar ataxia 24[1][2][3]. No drugs are currently known to directly target VPS13D, and it is not typically considered a standard therapeutic target in clinical pharmacology[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vacuolar protein sorting-associated protein 13D (VPS13D).